Otherwise a meta-analysis by Early Breast Cancer Trialists' Collaborative Group (EGCTCG) found tamoxifen improves relapse-free survival in case of ER positive tumors, regardless of PR status [23]. The gene discussed is PGR; the disease is breast carcinoma.